SGAM
OMED

Smith Group Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Smith Group Asset Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-48,790
Closed -$1.26M – 459
2015
Q1 		$1.26M Buy
+48,790
New +$1.26M 0.04% 165